Original Research
Accepted on 15 Apr 2025
Impact of Secondary Hematologic Malignancies on Prognosis of Hodgkin’s Lymphoma Survivors
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1566063
Type at least 3 characters
1,820 articles
Original Research
Accepted on 14 Apr 2025
CD38 prognostic role in chronic lymphocytic leukemia patients treated with standard chemotherapy or targeted agents: a monocentric real-life experience
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1569707
Systematic Review
Published on 14 Apr 2025
Atopic dermatitis and lymphoma risk: a systematic review and meta-analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1580550
- 354 views
Original Research
Accepted on 11 Apr 2025
Analysis of Pharmacotherapeutic Approaches for Multiple Myeloma and Correlated Renal and Pulmonary Impairments: A Retrospective Real-World Registry Study in the Greater Gulf Region (REPAIR Study)
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1547138
- 252 views
Case Report
Accepted on 09 Apr 2025
Venetoclax combined with ATRA shows promising therapeutic potential for TFG::RARA variant APL：a case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1529640
Case Report
Published on 09 Apr 2025
CD20-positive peripheral T-cell lymphoma not otherwise specified: a case series and review of the literature
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1553969
- 266 views
Review
Accepted on 07 Apr 2025
Preventing Pneumococcal Infections in Patients With Hematological Malignancies: A Review of Evidence and Recommendations Based on Modified Delphi Consensus
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1546641
Original Research
Published on 07 Apr 2025
Artificial intelligence-assisted early screening of acute promyelocytic leukaemia in blood smears: a prospective evaluation of MC-100i
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1572838
- 334 views
Case Report
Published on 07 Apr 2025
Case Report: Radiological characteristics and pathological correlation analysis of extranodal Rosai-Dorfman disease of liver
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1484820
- 168 views
Review
Accepted on 03 Apr 2025
A potential prognostic marker for hematologic neoplasms: CD58
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1586842
Case Report
Accepted on 03 Apr 2025
Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e13a3 fusion transcripts in a Patient with Pre-existing Essential Thrombocythemia: A Case Report and Literature Review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1573893
Perspective
Published on 01 Apr 2025
Total skin electron beam therapy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1498855
- 249 views
Case Report
Published on 01 Apr 2025
18F-FDG PET/CT in the diagnosis and treatment of atypical extensive skin lesions in extranodal natural killer/T-cell lymphoma, nasal type: a case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1480661
- 234 views
Review
Accepted on 31 Mar 2025
Targeting BCL2 in Waldenström Macroglobulinemia: From biology to treatment management
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1564869
- 129 views
Original Research
Published on 31 Mar 2025
Increased TIGIT expression correlates with impaired NK cell function in diffuse large B-cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1551061
- 423 views
Original Research
Published on 31 Mar 2025
The association of FAT1 mutations with therapeutic outcomes in AML, especially in receiving venetoclax combination
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1456832
- 268 views